Literature DB >> 2713105

[The primary structure of crystallizable monoclonal immunoglobulin IgG1 Kol. II. Amino acid sequence of the L-chain, gamma-type, subgroup I].

H D Kratzin1, W Palm, M Stangel, W E Schmidt, J Friedrich, N Hilschmann.   

Abstract

The immunoglobulin Kol was the first intact antibody molecule which was characterized by high-resolution X-ray crystallography. Furthermore the complete amino-acid sequence of the heavy (H)-chain is known. Here we report the complete amino-acid sequence of the light (L)-chain of the monoclonal immunoglobulin Kol (IgG1). The polypeptide has an Mr of 22,781, consists of 216 amino acids and due to its structure is of the lambda-type. With the characteristic amino acids threonine, asparagine, threonine, glycine and lysine in positions 101, 114, 116, 154, and 165, respectively the Kol L-chain is of the Mcg isotype. With the proteins Mcg, Mot, Bur, Loc and Mem six myeloma-derived amino-acid sequences of the same isotype are known. The amino-acid sequence of the N-terminal variable part is characteristic of subgroup 1. This contribution completes the primary structure of IgG1 Kol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713105

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  10 in total

1.  Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.

Authors:  Andreas Lehmann; Josephine H F Wixted; Maxim V Shapovalov; Heinrich Roder; Roland L Dunbrack; Matthew K Robinson
Journal:  MAbs       Date:  2015-09-04       Impact factor: 5.857

2.  Structural predictions of the binding site architecture for monoclonal antibody NC6.8 using computer-aided molecular modeling, ligand binding, and spectroscopy.

Authors:  M Viswanathan; J M Anchin; P R Droupadi; C Mandal; D S Linthicum; S Subramaniam
Journal:  Biophys J       Date:  1995-09       Impact factor: 4.033

3.  Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12.

Authors:  Yunji Wu; Anthony P West; Helen J Kim; Matthew E Thornton; Andrew B Ward; Pamela J Bjorkman
Journal:  Cell Rep       Date:  2013-12-05       Impact factor: 9.423

4.  Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.

Authors:  Kathrin Andrich; Ute Hegenbart; Christoph Kimmich; Niraja Kedia; H Robert Bergen; Stefan Schönland; Erich Wanker; Jan Bieschke
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

5.  Size and conformational features of ErbB2 and ErbB3 receptors: a TEM and DLS comparative study.

Authors:  Ernesto Vicente-Alique; Rafael Núñez-Ramírez; Juan Francisco Vega; Ping Hu; Javier Martínez-Salazar
Journal:  Eur Biophys J       Date:  2011-04-08       Impact factor: 1.733

6.  Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding.

Authors:  H Leibiger; D Wüstner; R D Stigler; U Marx
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

Review 7.  Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individuals.

Authors:  Nina G Bozhanova; Andrew I Flyak; Benjamin P Brown; Stormy E Ruiz; Jordan Salas; Semi Rho; Robin G Bombardi; Luke Myers; Cinque Soto; Justin R Bailey; James E Crowe; Pamela J Bjorkman; Jens Meiler
Journal:  Nat Commun       Date:  2022-06-08       Impact factor: 17.694

8.  Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab.

Authors:  Giovanna Scapin; Xiaoyu Yang; Winifred W Prosise; Mark McCoy; Paul Reichert; Jennifer M Johnston; Ramesh S Kashi; Corey Strickland
Journal:  Nat Struct Mol Biol       Date:  2015-11-23       Impact factor: 15.369

9.  Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation.

Authors:  Stephane Duquerroy; Enrico A Stura; Stéphane Bressanelli; Stella M Fabiane; Marie C Vaney; Dennis Beale; Maureen Hamon; Paolo Casali; Felix A Rey; Brian J Sutton; Michael J Taussig
Journal:  J Mol Biol       Date:  2007-03-06       Impact factor: 5.469

10.  Three-dimensional structure of the human myeloma IgG2.

Authors:  Sergey Ryazantsev; Vladimir Tischenko; Christopher Nguyen; Vyacheslav Abramov; Vladimir Zav'yalov
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.